IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

CALLOWAY COUNTY, Ky. — Law enforcement arrested a Murray woman Friday, making her the third person charged in connection to a fatal suspected arson on Saddlebrook Lane. According to the Calloway ...

2025-26 Cadillac Vistiq recalled over power-folding seat risk, including Australia The Cadillac Vistiq has been recalled globally – including in Australia – due to a potential fault with its ...

CHICAGO – First baseman Willson Contreras, expected to participate in the Home Run Derby on Monday and for the AL All-Star team on Tuesday at Citizens Bank Park in Philadelphia, won’t take his next ...

GM halted 2027 Cadillac Vistiq shipments amid a third-row seat recall The recall covers 14,540 SUVs with a seatback that can trap a child while folding Dealers will disable the folding function until ...

Earlier this year, the tragic death of a two-year-old in Ohio pushed Hyundai to issue a global recall for the Palisade. The problem was alarming enough on its own. The second- and third-row seats ...

The Russell Youth Trap team capped off another impressive season recently with a third place finish at the Kansas State High School Clay Target League State Tournament held on June 20 and 21 in ...

Cadillac is recalling more than 14,000 2026 and 2027 model year Vistiq SUVs over a defect that could turn a convenience feature into a safety hazard. The electric SUV's one-touch power-folding ...

The Vistiq's third-row seat can trap occupants, prompting a recall and stop-sale order for all Cadillac dealerships. Cadillac has ordered dealers to stop selling the 2026 and 2027 Vistiq three-row ...

Cadillac has ordered dealers to stop selling the 2026 and 2027 Vistiq three-row electric crossover due to a new recall campaign targeting its third-row seat. According to the manufacturer, the seat’s ...

Identification of novel CD8+ immune epitopes relevant for EBV-related cancers. This is an ASCO Meeting Abstract from the 2026 ASCO Breakthrough. This abstract does not include a full text component.